Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2000
10/24/2000CA2113106C Fluorescent microparticles with controllable enhanced stokes shift
10/24/2000CA2077452C Automated biological reaction apparatus
10/24/2000CA2005955C Synthetic hiv-like peptides, their compositions and uses
10/23/2000CA2306059A1 Dual transmitter multi-capacitance flow meter
10/22/2000WO2001012067A1 Method of detecting cancerous lesions
10/22/2000CA2306060A1 Apparatus and method for evaluating quality of granular object
10/22/2000CA2291914A1 Improved immunochromatographic assay
10/20/2000CA2306179A1 Fatty acid derivative labeled with a radioactive transition metal
10/19/2000WO2000062351A1 Methods of forming monolayers and uses thereof
10/19/2000WO2000062105A1 Reflectively coated optical waveguide and fluidics cell integration
10/19/2000WO2000062077A1 Procoagulant assay
10/19/2000WO2000062076A1 Galectin expression is induced in cirrhotic liver and hepatocellular carcinoma
10/19/2000WO2000062075A1 Ubiquitin cross-reactive protein as a prognostic marker for tumor cell chemosensitivity
10/19/2000WO2000062074A1 Use of 13c-nmr to detect binding
10/19/2000WO2000062073A1 Method for analyzing the amount of intraabdominal adipose tissue
10/19/2000WO2000062072A1 Homogeneous detection and/or determination method for a chemical or physico-chemical interaction
10/19/2000WO2000062071A1 Diagnostic and therapeutic use of antibodies against the urokinase receptor
10/19/2000WO2000062070A2 Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker
10/19/2000WO2000062069A1 Method of detecting intimin-expressing microorganisms
10/19/2000WO2000062068A1 Method to type prion proteins
10/19/2000WO2000062067A1 Novel transduction molecules and methods for using same
10/19/2000WO2000062066A1 METHOD FOR JUDGING AUTOIMMUNE DISEASE, METHOD FOR DETECTING ANTI-Reg PROTEIN AUTOANTIBODY AND DIAGNOSTICS FOR AUTOIMMUNE DISEASES
10/19/2000WO2000062065A1 Complex formed by n-linked glycoproteins (siblings) and factor h
10/19/2000WO2000062064A2 Quality control for cytochemical assays
10/19/2000WO2000062063A1 Methods for the diagnosis and treatment of metastatic prostate tumors
10/19/2000WO2000062062A1 METHOD FOR QUANTIFYING TRANSFORMING GROWTH FACTOR-β1 AND METHOD FOR DETECTING CANCER BY USING SAME
10/19/2000WO2000062061A1 Device and method for use in receptor-ligand and affinity tests
10/19/2000WO2000062060A2 Method for detection of analytes in urine using lateral flow hybrid device
10/19/2000WO2000062059A1 Apparatus and method for kinetic analysis of the intraoperative assay for parathyroid hormone
10/19/2000WO2000062058A1 Methods and apparatus for estimating the oxidative stability of an oxidizable material
10/19/2000WO2000062057A1 Method and device for controlling a vat containing oil or cooking fat in situ
10/19/2000WO2000062056A1 Semiconductor gas sensor with housing and method for measuring of gas concentrations
10/19/2000WO2000062046A1 Thin-film semiconductor gas sensor and method of detecting gases
10/19/2000WO2000062036A1 Amplification and separation of nucleic acid sequences using strand displacement amplification and bioelectronic microchip technology
10/19/2000WO2000062023A1 Fta-coated media for use as a molecular diagnostic tool
10/19/2000WO2000061865A1 Correction of measurements with sensors affected by several properties of a material
10/19/2000WO2000061816A1 Electronically mediated nucleic acid amplification in nasba
10/19/2000WO2000061814A1 Detection of chromosome copy number changes to distinguish melanocytic nevi from malignant melanoma
10/19/2000WO2000061813A1 A second mammalian tankyrase
10/19/2000WO2000061808A2 Methods for detecting nucleic acids indicative of cancer
10/19/2000WO2000061806A2 GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS
10/19/2000WO2000061805A1 Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip
10/19/2000WO2000061802A2 Method and kitset for sampling and storage of biological samples
10/19/2000WO2000061798A2 Method for mapping a dna molecule comprising an ad infinitum amplification step
10/19/2000WO2000061793A2 Novel method for identifying antibacterial compounds
10/19/2000WO2000061792A1 Novel essential bacterial genes and their proteins
10/19/2000WO2000061790A1 High sensitivity phage display biomolecule detection
10/19/2000WO2000061781A1 Cyclic gmp dependent protein kinase as a chemotherapeutic target for antiprotozoal agents
10/19/2000WO2000061779A1 49 human secreted proteins
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061769A1 ALKALINE PROTEASE VapK SUITABLE FOR LAUNDRY DETERGENT, vapk GENE, RECOMBINANT EXPRESSION VECTOR, AND TRANSFORMED MICROORGANISMS
10/19/2000WO2000061756A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000WO2000061755A2 Secreted human proteins
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061753A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/19/2000WO2000061751A1 REAGENTS AND METHODS FOR IDENTIFYING AND MODULATING EXPRESSION OF GENES REGULATED BY p21
10/19/2000WO2000061750A2 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
10/19/2000WO2000061748A1 48 human secreted proteins
10/19/2000WO2000061746A1 13 transmembrane protein expressed in prostate cancer
10/19/2000WO2000061739A1 Method for controlling the activity of immunologically functional molecule
10/19/2000WO2000061728A2 Human elastase i
10/19/2000WO2000061724A2 Anti-bacterial vaccine compositions
10/19/2000WO2000061636A2 Aberrantly glycosylated antibodies as marker for cancer
10/19/2000WO2000061629A1 49 human secreted proteins
10/19/2000WO2000061628A1 49 human secreted proteins
10/19/2000WO2000061627A1 49 human secreted proteins
10/19/2000WO2000061626A1 49 human secreted proteins
10/19/2000WO2000061625A1 48 human secreted proteins
10/19/2000WO2000061624A1 48 human secreted proteins
10/19/2000WO2000061623A1 62 human secreted proteins
10/19/2000WO2000061622A2 Genes associated with diseases of the kidney
10/19/2000WO2000061621A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061614A2 Uncoupling proteins
10/19/2000WO2000061612A2 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000WO2000061597A1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
10/19/2000WO2000061596A1 50 human secreted proteins
10/19/2000WO2000061295A1 Centrifuging device and use of same
10/19/2000WO2000061281A1 Encoding scheme for solid phase chemical libraries
10/19/2000WO2000061256A1 Method and apparatus for producing platelet rich plasma and/or platelet concentrate
10/19/2000WO2000061198A1 Method of producing probe arrays for biological materials using fine particles
10/19/2000WO2000061197A1 Assessment of gastric emptying disorders
10/19/2000WO2000061195A1 Benzodiazepine derivatives for imaging thrombi
10/19/2000WO2000061180A2 Products and methods for treating ptp lar related diseases
10/19/2000WO2000061167A2 TREATMENT OF MYELOMA BONE DISEASE WITH PROTEASOMAL AND NF-λB ACTIVITY INHIBITORS
10/19/2000WO2000061132A1 Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to a graft
10/19/2000WO2000061067A2 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein
10/19/2000WO2000061002A1 Assessment of psychiatric and neurological conditions
10/19/2000WO2000060932A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1
10/19/2000WO2000037941A3 A METHOD OF DETECTING AND/OR QUANTIFYING A SPECIFIC IgE ANTIBODY IN A LIQUID SAMPLE
10/19/2000WO2000036420A3 Differential expression in primary breast cancer
10/19/2000WO2000034780A3 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3?
10/19/2000WO2000034485A3 Beta-1,3-galactosyltransferase homologs
10/19/2000WO2000034296A3 Conjugates comprising galactose alpha 1,3 galactosyl epitopes and methods of using same
10/19/2000WO2000033872A3 Method of and compositions for immunization with the pseudomonas v antigen
10/19/2000WO2000032809A3 Cloning and copying on surfaces
10/19/2000WO2000032778A3 Methods and compositions for inhibiting neoplastic cell growth
10/19/2000WO2000032769A3 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides
10/19/2000WO2000032224A3 Calcitonin for the modulation of sperm function
10/19/2000WO2000031294A3 Method for identifying cytosine methylation patterns in genomic dna
1 ... 3062 3063 3064 3065 3066 3067 3068 3069 3070 3071 3072 3073 3074 3075 3076 3077 3078 3079 3080 3081 3082 ... 3937